Japan · Delayed Price · Currency is JPY Japan Tobacco Earnings Call Transcripts
Fiscal Year 2025
-
Record FY2025 results driven by tobacco and RRP growth, with Ploom Aura expanding to 19 markets and strong pricing power offsetting industry headwinds. FY2026 guidance targets continued profit and cash flow growth, with sustained investment in innovation and shareholder returns.
-
Nine-month results showed strong growth in revenue, profit, and market share, driven by robust tobacco business performance and the Vector Group acquisition. Outlook for FY2025 is revised upward, with record highs expected and a higher dividend. Risks include potential tax hikes in Russia and ongoing inflation in Turkey.
-
Strong first-half results with double-digit AOP and revenue growth, driven by organic momentum and the Vector acquisition. Full-year guidance for revenue and profit was revised upward, while free cash flow was revised down due to litigation and working capital. Dividend guidance was also raised.
-
Strong Q1 2025 results driven by tobacco pricing and Vector acquisition, with AOP up 20.8% year-on-year. Pharmaceutical business to be sold to Shionogi, impacting FY2025 profit by JPY 6 billion but not dividends. Outlook remains positive, with steady growth expected and new Ploom device launch ahead.
Fiscal Year 2024
-
Record-high revenue and AOP were achieved in 2024, led by strong tobacco and RRP growth, with the Vector acquisition set to boost 2025 results. High single-digit AOP growth at constant FX is targeted through 2027, with continued strategic investments and a stable dividend policy.
-
Revenue and AOP rose year-on-year, driven by strong tobacco pricing and Ploom growth, while the Vector acquisition boosts US market share and future profit potential. Full-year guidance was revised upward, but profit is tempered by higher costs and Canadian litigation risks.
-
Revenue, profit, and free cash flow all rose year-on-year, driven by strong tobacco pricing and RRP growth. Full-year forecasts for revenue, AOP, and profit were revised upward, while supply chain and FX headwinds remain key risks.